(Q46025286)

English

Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.

scientific article published on 22 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

gastroesophageal reflux disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Vijaya Pratha

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Daniel L Hogan

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Richard B Lynn

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Brian Field

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

David C Metz

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

publication date

22 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

51

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

1595-1601

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Prevention of erosive oesophagitis relapse with pantoprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positioning of Subject and of Nasogastric Tube during a Gastric Secretion Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16927137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-006-9108-2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16927137

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46025286&oldid=2207539180"